These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers. Johansson B; Ridderheim M; Glimelius B Acta Oncol; 2005; 44(8):890-5. PubMed ID: 16332598 [TBL] [Abstract][Full Text] [Related]
48. Comparison between in-beam and offline positron emission tomography imaging of proton and carbon ion therapeutic irradiation at synchrotron- and cyclotron-based facilities. Parodi K; Bortfeld T; Haberer T Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):945-56. PubMed ID: 18514787 [TBL] [Abstract][Full Text] [Related]
49. Feasibility of using internal radiation-generating devices in radiotherapy. Bevelacqua JJ Health Phys; 2010 Apr; 98(4):614-20. PubMed ID: 20220369 [TBL] [Abstract][Full Text] [Related]
50. The proton beam debate: are facilities outstripping the evidence? Goozner M J Natl Cancer Inst; 2010 Apr; 102(7):450-3. PubMed ID: 20339139 [No Abstract] [Full Text] [Related]
51. Technology for proton therapy. Flanz J; Smith A Cancer J; 2009; 15(4):292-7. PubMed ID: 19672145 [TBL] [Abstract][Full Text] [Related]
52. Clinical results of proton beam therapy for cancer of the esophagus. Sugahara S; Tokuuye K; Okumura T; Nakahara A; Saida Y; Kagei K; Ohara K; Hata M; Igaki H; Akine Y Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):76-84. PubMed ID: 15629597 [TBL] [Abstract][Full Text] [Related]
53. [Conformational radiotherapy for bladder cancer: limits to precision and potential advantages of the utilization of proton beams]. Miralbell R Arch Esp Urol; 1999; 52(6):684-91. PubMed ID: 10484852 [TBL] [Abstract][Full Text] [Related]
55. Dosimetry of clinical neutron and proton beams: an overview of recommendations. Vynckier S; ; Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710 [TBL] [Abstract][Full Text] [Related]
56. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Langendijk JA; Lambin P; De Ruysscher D; Widder J; Bos M; Verheij M Radiother Oncol; 2013 Jun; 107(3):267-73. PubMed ID: 23759662 [TBL] [Abstract][Full Text] [Related]
57. A Tandetron™ as proton injector for the eye tumor therapy in Berlin. Röhrich J; Damerow T; Hahn W; Müller U; Reinholz U; Denker A Rev Sci Instrum; 2012 Feb; 83(2):02B903. PubMed ID: 22380335 [TBL] [Abstract][Full Text] [Related]